The 5-HT 2A receptor is known to act as the biological target for a series of hallucinogenic substances including substituted phenylalkylamines, tryptamines and LSD. A prerequisite for a hallucinogenic effect is an agonistic binding mode to the high-af®nity state of the receptor. Attempts to establish a quantitative structure-activity relationship for such compounds are typically based on homology models or 3D-QSAR.
In this paper, we describe a surrogate for the 5-HT 2A receptor derived by means of quasi-atomistic receptor modeling (software Quasar), a more recently developed 3D-QSAR technique. This approach allows for the simulation of local induced ®t, H-bond¯ip-¯op, and solvation phenomena. The QSARs are established based on a family of receptor-surface models, generated by a genetic algorithm combined with cross-validation. The surrogate for the 5-HT 2A receptor yielded a cross-validated q 2 of 0.954 for the 23 compounds de®ning the training set. A series of 7 test compounds was then used to validate the model, resulting in a RMS deviation of 0.40 kcalymol between DG 0 prd. and DG 0 exp. . The largest individual deviation was 0.61 kcaly mol, corresponding to an uncertainty of a factor 2.7 in the binding af®nity. A scramble test with negative outcome (q 2 0.144, slope 7 0.019) demonstrates the sensitivity of the model with respect to the biological data. Subsequently, the surrogate was used to estimate the activity of a series of 53 hypothetical congeneric compounds, some of which are predicted to be close in activity to LSD.
Introduction
Hallucinogens are substances which provoke far-reaching and thorough mental and psychic changes including disorientation, derealization, and depersonalization, whereas consciousness and memory seem to remain unaltered. According to their chemical structure, hallucinogensÐin the strictest senseÐcan be classi®ed as phenylalkylamines (phenethylamines and amphetamines), indolealkylamines such as tryptamines and ergolines such as LSD. Large numbers of derivatives of such compounds are synthesized by chemists in underground laboratories and subsequently misused as designer drugs. The driving force behind such illicit activity is to produce substances with stronger psychological effects by minorÐoften arbitraryÐvariations of the molecular structures. Aiming at a more effective criminal prosecution and a faster registration of substances with a dependency and abuse potential, the prediction of the effects and binding af®nities of new hallucinogens or designer drugs is highly desirable.
The 5-HT 2A receptor is known to act as the biological target for a series of hallucinogenic substances including substituted phenylalkylamines, tryptamines, and LSD [1] . Prerequisites for a hallucinogenic effect include an agonistic binding behaviour for the high-af®nity state of the receptor. In addition, a protonated N atom (aminoethyl side chain of the phenylalkylamines and tryptamines or ring D of LSD, respectively; cf. Figure 1 , Table 1 ) is also mandatory, whereby a primary amine functionality yields optimal activity. Hydroxylation and methoxylation of position 2 of the phenylalkylamines or position 5 of the tryptamines and substitution with hydrophobic groups (e.g. halide atoms) in position 4 of the phenylalkylamines or position 7 of the tryptamines leads to a greatly increased af®nity towards the 5-HT 2A receptor. The receptor also exhibits stereoselectivity for the R-enantiomer of the phenylalkylamines and the S-enantiomer of the tryptamines. For an overview of pharmacology and structure-activity relationships, see, for example, refs. 2±8. [9, 12, 13] .
To understand the activity of hallucinogenic substances at the molecular level, several receptor models for the 5-HT 2A receptor have been constructed, and numerous 3D-QSAR studies were carried out [14±23] . Since the three-dimensional structure of the 5-HT 2A receptor is not presently available, various molecular models have been generated in homology to the structure of bacteriorhodopsin, which has been determined by means of high-resolution electron cryomicroscopy [24] . Bacteriorhodopsin acts as a proton pump and has a different signal-transduction pathway. Not surprisingly, an apparent lack of primary sequence homology is observed between the two proteins. Consequently, models for the 5-HT 2A receptor based on the structure of bacteriorhodopsin should be interpreted cautiously. To establish a 3D-QSAR on the other hand, no direct knowledge of the receptor topology is necessaryÐunfortunately, however, most of the studies were based on data sets consisting only of hallucinogen subgroups such as the phenylalkylamines or tryptamines [20±22, 25] .
Here we present a study combining a more diverse data set including phenylalkylamines, tryptamines and LSD (an ergoline) as hallucinogens and also entactogenic substances. The term entactogen (lat. tactus to touch, griech. en within, griech. gen to produce) was ®rst introduced by Nichols [26] and stands for``to produce a touching within''. It describes the unique effects of this substance class which acts by enhancing the readiness to communicate rather than being hallucinogenic. A new 3D-QSAR approach named quasi-atomistic receptor modeling (software Quasar) was also used. This technique bridges 3D-QSAR and receptor ®tting by combining receptor-surface models populated with atomistic properties (hydrogen bonds, salt bridges, aromatic and aliphatic regions, solvent) and individually adapted ligand-surrogate envelopes, simulating a¯exible receptor cavity [27] . In contrast to other 3D-QSAR approaches, problems associated with the various ligand molecules binding to aǹ`a veraged receptor model'' are avoided, as the adaption of the receptor-envelope to the individual ligand topologies is simulated (local induced-®t mechanism). Moreover, H-bond ip-¯op and simulation of solvation effects are included in the algorithm. H-bond¯ip-¯op particles would seem to be particularly important as they are capable of mimicking amino-acid residues at the true biological receptor (Ser, Thr, Tyr, Cys, His, Asn and Gln) capable to engage in differently directed hydrogen bonds with different ligand molecules. This is of utmost importance in a virtual experiment where a series of ligand molecules binds``simultaneously'' to the receptor surrogate. In addition, a solventaccessible binding pocket or different degrees of binding-site tightness may be simulated. Ligand-receptor interactions are evaluated based on a directional force ®eld for hydrogen bonds and salt bridges which allows for the simulation of ligand selectivity, including the discrimination of stereoisomers [27] .
Based on a series of ligand molecules with individually adapted receptor envelopes (training set), Quasar allows to generate a family of receptor models using a genetic algorithm combined with cross-validation. Model building involves the following basic steps:
(1) Construction of a receptor envelope and its individual adaption to the topology of the very ligands. Finally, the obtained model family must be validated through an external set of ligand molecules not used for model construction (test set). The sensitivity towards the biological data (i.e. the binding af®nities) may be established by means of a scramble test. Here, the DG 0 data of the training set are randomly scrambled with respect to the true biological values and the simulation is repeated under otherwise identical conditions. If a solution for the ligands of the training set is nonetheless found and if the ligands of the test set are predicted similarly wellÐwhen compared with the true simulation using unscrambled DG 0 dataÐthe model is worthless as it is not sensitive to the biological data it should establish a QSAR for. If the genetic algorithm even fails to identify a reasonable model for the scrambled training set, force-®eld and the model surrogate are thought to adequately represent the interaction at the true biological receptor.
In the present investigation the validated family of quasiatomistic receptor models for the 5-HT 2A receptor is subsequently used for predictions of the binding af®nities of 53 congeneric compounds, most of them not yet synthesized and tested for af®nity towards the 5-HT 2A receptor. Due to the structural resemblance of these molecules to hallucinogenic templates one can assume that the new substances which possess a high binding af®nity for our system might possibly also act as potent hallucinogens.
Methods

Selection of the Data Set
For our study, radioligand-binding data determined for the rat-brain cortical 5-HT 2A receptor labelled with the antagonist [ 3 H] ketanserin were used (cf. 
, a more speci®c antagonist for the 5-HT 2A receptor than ketanserin for which only insuf®cient data exists. As for the safe validation of a receptor surrogate at least 20±30 substances are recommended [37] , we had to select the mixed-mechanism approach with the biological data determined against [ 3 H] ketanserin. The scramble test (cf. below) did, however, demonstrate a suf®-ciently high sensitivity towards the biological data, thus, supporting the assumption that the systematic error possibly introduced by the mixed-mechanism approach is comparable in magnitude for all substances tested.
The various phenylalkylamine and a-methylated tryptamine ligands used in our study exist in two stereoisomeric forms. As frequently observed with chiral bioligands, the different isomers display a different biological activity: for the phenylalkylamine ligands the R-enantiomer is the more active one while for the tryptamine ligands the S-enantiomer is more potent. For a statistical signi®cant validation of the receptor surrogate, the binding af®nity of the ligands of the training set should preferably span 3 to 4 orders of magnitude in their af®nity towards the true biological receptor [37, 38] , a requirement which is met by our ligand data set (cf. Table 2 ).
Building of the MoleculesyGeometry OptimizationyConformational Search
The three-dimensional structures of the 5-HT 2A agonists (cf. Table 1) were constructed using the X-ray crystal structures of 4-ethyl-2,5-dimethoxyamphetamine, 5-hydroxy-N,N-dimethyltryptamine and LSD [39±41] as templates and the model building tools of the SYBYL 6.3 software [42] . All molecules were generated in the N-protonated form, as this tautomer prevails at physiological pH (pH 7.4) [2, 43] at which the af®nity was determined [28±35].
The initial geometry optimization was performed in vacuo using the Tripos standard force ®eld [44] . Subsequently, we explored the conformational space of each of the ligand molecules by scanning all rotatable bonds in 5-degree increments and retained all conformers re®ned to within 20 kcalymol of the global energy minimum. The ensemble of structures was then sampled and analyzed by means of the software Starmaker and Starcompare [45] in order to identify a common spatial orientation of the protonated N atom as a pharmacophorically important group among the phenylalkylamines and the tryptamines.
A ®rst pharmacophore model was based on the superposition of the atoms de®ning the aromatic six-membered ring (henceforth referred to as the primordial alignment). The second hypothesisÐused for the Quasar studyÐincluded the energy minimization of the ligands of the primordial alignment and the superimposition of the N-atom, its proton and the aromatic ring (for details of this technique, cf. ref. 38 ). All ligand molecules were subsequently re®ned in aqueous solution using the MM2 force-®eld as implemented in MacroModel 6.0 [46] . Electrostatic partial charges and solvation energies were then calculated using the AMSOL 6.4 software package [47] . Thereafter, the alignment of the ligand molecules was adjusted a ®nal time.
Quasar: Construction of Quasi-Atomistic Receptor Models and Estimation of Relative Free Energies of Ligand Binding
Quasi-atomistic receptor modeling (software Quasar [27] ) allows the construction of a receptor-surface modelÐa threedimensional envelope, populated with atomistic propertiesÐ about any molecular framework of interest, e.g. a pharmacophore. Based on our pharmacophore hypothesis (cf. above)Ðprior to the analysisÐ23 substances of the data set were de®ned as a training set, 7 substances (S2, S4, S6, S11, S14, S17, S26) as a test set. The selection of the ligands for the training and the test set followed the regulation of each functional group of the test set being implemented in the training set to avoid extrapolation of the afterwards obtained results. For the training set of ligand molecules an``averaged receptor envelope'' using the default-values was generated. The envelope was optimized by means of energy minimization and adapted to each ligand molecule of both training and test set as a (1 : 1) ligand-receptor complex, thus allowing for individual adaption of the receptor envelope to the respective ligand topology.
Using a genetic algorithm an initial population of 200 receptor models was developed using both cross-over and mutation events. For generation of the models default values were used with exception of the following ones: ligandreceptor polarization was enabled, the weighting of solvation effect was set to 0.1, 4 cross-validation groups were used, and the site-saturation rate was set to 0.6. The optimal duration of the evolution was determined by a series of identical simulations differing solely in the maximum number of evolution steps (1000, 2000, . . . , 10 000) and was set to 8000.
In the Quasar concept [27] , the approach of Blaney et al. [48] for estimating the binding energy of an individual ligand molecule bound to a macromolecular receptor, E bdg. , is augmented by two terms accounting for the change in ligand-internal energy [see also refs. 38, 49] and local induced ®t, respectively:
The ligand-receptor interaction energy, E lig-rec , is determined by means of a directional force ®eld [27, 38, 49, 50] . The entropy term, TDS bdg. , is calculated based on the number of freely rotatable bonds, excluding terminal methyl groups [51] . Other criteria include the cross-validated q 2 value, the lack-of-®t (cf. ref. 27 ) for the ligands of the training set as well as the uniformness of the distribution of the properties mapped onto the receptor envelope, e.g. larger hydrophobic areas or solvent-accessible regions. Finally, the number and distribution of the atomistic properties might also represent valuable criteria.
Prediction of Binding Af®nities of New Compounds
The model family was then used to predict the binding af®nities of 53 compounds, most of which have not yet been synthesized and tested (cf. Figure 5 , Table 3 ). For these compounds, conformational search, alignment and construction of individual ligand envelopes in Quasar were carried out under the same conditions as for the training and the test set.
A simultaneous consideration of all rotatable bonds for ligands such as ko3 would lead to a too large number of possible conformers and a more dif®cult evaluationyinterpretation of the results. So for this ligands all of the rotatable bonds were evaluated step by step. After every conformational search the molecules were again energy minimized and the total energy was checked. As reference points the corresponding atoms of the amide side-chain of the LSD-molecule were chosen and every conformer was compared with this (software StarmakeryStarcompare, cf. above).
Results and Discussion
The relative alignment of substituted derivatives of both tryptamines and phenylalkylamines is often discussed controversially (see, e.g., refs. 14, 25, 32, 53, 54). In our primordial pharmacophore model, the aromatic ring systems were oriented analogously to a previous study in our laboratory [25] and in agreement with other 3D-QSAR simulations [14, 32, 54] . As the ammonium functionality has been shown to engage in a strong salt bridge with an aspartate residue at the true biological receptor [55] , we selected a more stringent alignment protocol (cf. above), where special emphasis was put on the spatial orientation of the b N-H3H-bond donor. This was accomplished by means of a vector-alignment concept (H-extension and lone-pair vectors associated with ideal H-bond geometries; for details, see ref. 50 ). Comparison of these vectors and the electrostatic ®eld exerted by the ligand molecules suggests thatÐin spite of the structural differenceÐphenylalkylamines, tryptamines, and ergolines might well bind to the same receptor site displaying a similar topology. Such a protocol has been referred to as receptor mediated alignment [38] . The ligand superposition is shown in Figure 2 .
Using a population of 200 receptor models, the systemÐ comprising 23 ligand molecules of the training set and the enclosing individual envelopes, each de®ned by 238 discrete positionsÐwas allowed to evolve for 8000 cross-over cycles. The transcription-error rate (expressed by random mutations) was set to 0.02 and the minimal difference between any of the receptor models was required to be at least 0.1, i.e. 24 of the 238 properties. A test set of seven ligand molecules was then used to validate the model. Here, the RMS deviation of experimental and predicted free energies of ligand binding was calculated to be 0.40 kcalymol. The largest individual deviation, obtained for ligand S2, was 0.61 kcalymol which corresponds to an uncertainty in the binding af®nity of a factor 2.7. A summary Figure 2 . Stereoview of the ligand alignment used for the Quasar study. of the results is given in Table 2 ; the receptor surrogate is shown in Figure 3 ; experimental and predicted binding af®nities are compared in Figure 4 .
Because DG 0 prd. is averaged over the n members (here n 200) of the receptor family in the Quasar concept, each value is associated with a standard deviation S Ki , describing the variation over the various individual models. This value may be interpreted in terms of a safe or less safe prediction of an individual compound. For ligand molecules de®ning the training set, this range is typically rather narrow; of greater interest, however, are the corresponding values of the test set. For the 5-HT 2A receptor, the largest variation of DG 0 prd.
within the training set was observed for ligand S9 (s 0X17 kcalymol); for the test set, ligand S26 displayed the largest variation (s 0X18 kcalymol). These comparable values suggest that the training-set selection is representative for the ligand molecules de®ning the test set. The individual DG 0 -values, converted into K i -values, are given in Table 2 . Next, we performed a scramble test using a randomly scrambled DG 0 exp. data for the ligands of the training set but otherwise identical settings for the simulated evolution. The simulation yielded a cross-validated q 2 of 0.144 (normal simulation: 0.954) with individual deviations as large as 2.8 kcalymol, corresponding to an uncertainty in the binding af®nity of a factor 96. The low q 2 and the negative slope of the regression (a À0.019) indicate that the receptor-surrogate is indeed sensitive to the biological data it should establish a QSAR for (cf. Figure 4) . A ®nal simulation explicitly allowing for a solvent-accessible binding pocket led to slightly inferior results, suggesting that solvent might not be involved in ligand binding at the true biological receptor.
Finally, the quasi-atomistic receptor surrogate was used to predict the activity of a series of 53 congeneric ligands (cf. Figure 5 , Table 3 ). Based on their structural resemblance to hallucinogenic templates they are believed to display a potential hallucinogenic activity in man. True predictions should always be interpreted with care as the possibility of an extrapolation with respect to the topologies and the functionalities within the training set can seldom be fully excluded. When using a genetic evolved family of receptor models, the variation of the predicted activities within the individual models may provide a hint whether or not extrapolation might be present. The ultimate assessment is given by the subsequent (or independent) synthesis and determination of the biological activity. With respect to our candidate molecules, this is indeed the case for some of the compounds which shall, therefore, be discussed in more detail.
Compound pm8, a rigid congener of DOB with a bromo substituent in position 4 was predicted with a high binding af®nity of K i 19 nM (cf. Table 4 ). Independently to this study, the compound pm8 was synthesized as a racemate and tested by Parker et al. [56] . It was shown to be a very potent derivative which even slightly surpassed LSD in potency and is so far the most potent ligand known for the 5-HT 2A receptor. As can be seen from experimental data (cf. Table 2 ), DOI possesses a higher binding af®nity for the [ 3 H] ketanserin labeled 5-HT 2A receptor of the rat than DOB. Thus, one could expect to improve the activity of pm8 by exchange of the bromo substituent by a iodo substituent. As is shown by our study the corresponding iodo congener pm9 (not synthesized and tested yet) has a predicted binding af®nity of K i 6.6 nM, higher than pm8. Congeneric ligands with CH 3 -, CF 3 -groups or H-atoms in position 4 are predicted with a lower af®nity ( 56 to 325 nM) which can be concluded from previous SAR-studies [4] and experimental data.
Compound pm6, a rigid analog of DOI, tethering the oxygen in position 2 into a ring system, was synthesized and tested independently by Monte [57] . The tethering of the oxygen in position 2 and 5 improves the activity of similar rigidi®ed difuranyl compounds as was shown by Monte et al. [58] .
Unfortunately the data of the pharmacological evaluations and the radioligand binding assays of pm6 are not yet available. However, our study suggests the predicted binding af®nity of pm6 (K i 8.1 nM) is higher than the experimental binding af®nity of DOI (K i 9.9 nM).
For the rigid naphthofurans pm1±pm4 only moderate activities (K i 74 nM through K i 6300 nM) are calculated. Surprisingly, pm1 shows a lower af®nity (K i 1019 nM) than pm3 (K i 319 nM). Typically, a ligand bearing a primary amine functionality displays the highest receptor af®nity [2, 4, 7] . On the other hand, pm4 with its N-(propyl) 2 substituent is predicted to be the weakest of this series (K i 6300 nM) which is in agreement to previous SARstudies. These results are also in accordance with studies by Monte et al. [59] who synthesized and tested rigid naphthofurans similar to pm1±pm4 and concluded that such compounds do not feature an active conformation, because of the loss of LSD-like behavioural effects.
Within the new phenylalkylamine and tryptamine derivativesÐapart from compound pn5 (cf. below)Ðonly two compounds were synthesized and tested: pn25 and pn27 [60] . Compound pn25 showed a relatively low activity in animal models which is in accordance with the moderate binding af®nity of K i 340 nM which is predicted by our study. The insertion of a bromo substituent leads according to SAR studies to an enhancement of the activity. In correspondence to this, the bromo derivative pn25 showed an enhanced activity in animal models and is also predicted in our model with an higher binding af®nity of K i 22 nM. These results suggest that our quasi-atomistic surrogate for the 5-HT 2A receptor might be useful for the estimation of the binding af®nity of hypothetical compounds and synthesis planning.
Within the candidate series pn1±pn16 compound pn5 is the only molecule for which results from a radioligand binding study are available [61] . This substance seems to surpass DOB in potency which would not seem to be in agreement with our predicted binding af®nity of K i 101 nM (DOB: K i 24 nM), because for halide substituents in position 4 a decrease in binding af®nity I b Br b F is observed. This is in accordance with ®ndings of Shulgin et al. [62] who examined a iodine substituent, the heaviest, was the most potent hallucinogen in this series. For a CF 3 -group no increase of the binding af®nity is generally calculated in our study (cf. pm9 b pm8 b pm16). But this might be a consequence of the fact that i.e. no¯uoro substituent was implemented in the training set.
According to our study, the highest binding af®nity of K i 3.2 nM was calculated for ko3. Assuming a maximal error of a factor of 10 in the prediction (cf. maximum error of the internal test set), this compound might be close in activity to LSD (K i 2.5 nM). This molecule represents a hybrid structure between LSD and a phenylalkylamine derivative such as DOI. It was developed expecting that the amideoxygen functionality provides additional chances for interactions with, for instance, a receptor's Asn. Also, the diethylsubstituent at the amide-N is expected to show additional interactions with a hydrophobic region of the receptor, e.g. Ile, Phe and Trp.
In summary, two compounds (ko3, ko2) have calculated activities of K i 5 nM; additional three compounds (pm9, pm6, pm5) lie in the range of 5 nM K i 10 nM. Only for pm8 which is predicted with a somewhat lower binding af®nity of K i 19 nM in vitro and in vivo data of the racemate exist until now. It is the most potent ligand for the 5-HT 2A receptor known at the moment.
Of course, a high binding af®nity is a mandatory but not suf®cient criterion for hallucinogenic activityÐevident for the S-enantiomer of DOI (K i 35 nM), a non-hallucinogenically active substance. But as we considered the more active R-enantiomer for the phenylalkylamine congeners and the corresponding S-enantiomer for the tryptamine congeners, and as furthermore all of our new substances are lipophilic enough due to several ring systems and in some cases the a-CH 3 group to pass the blood-brain barrier one can expect that substances which show a high predicted binding af®nity in our model, thus also act as hallucinogens in human.
Conclusions
Using quasi-atomistic receptor-modeling (software Quasar), a 3D-QSAR has been established for a series of 30 phenylalkylamine, indolealkylamine and ergoline derivatives, all known to bind to the 5-HT 2A receptor and most of them displaying hallucinogenic activity in man andyor behaviorally activity in animals. The Quasar approach allows for the simulation of local induced ®t, H-bond¯ip-¯op, and solvation phenomena. The QSARs are established based on a family of receptor-surface models, generated by a genetic algorithm combined with cross-validation. The receptor surrogate yielded a cross-validated q 2 of 0.954 for the 23 compounds de®ning the training set and a RMS deviation of DG 0 prd. and DG 0 exp. of 0.40 kcalymol for the seven test compounds used to validate the model, corresponding to an uncertainty of a factor 1.9 in the binding af®nity. The sensitivity of the model with respect to the biological data was demonstrated by means of a scramble test with negative outcome (q 2 0.144; slope À0.019).
The surrogate was then used to estimate the activity of a series of 53 hypothetical congeneric compounds, believed to act as hallucinogens due to their topological similarity to known active substances and their putative ability to traverse the blood-brain barrier.
The most promising candidate compound is a molecule which represents a hybrid structure between LSD and phe- nylalkylamines such as 2,5-dimethoxy-4-iodoamphetamine (DOI). The binding af®nity of this compound towards the 5-HT 2A receptor is predicted to be K i 3.2 nM, close to the experimental binding af®nity of LSD (K i 2.5 nM). Some of these compounds have been synthesized in the meantime, allowing for a critical evaluation of our model.
Supplementary Material
The three-dimensional coordinates of all ligand molecules used in this study and the quasi-atomistic receptor surrogate for the 5-HT 2A receptor are freely available for distribution through``karl-artu Ïr.kovar@uni-tuebingen.de''. Further information about recent developments of the Quasar software can be found at``www.biograf.ch''.
